Investor Presentation July 31, 2025 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of federal securities laws. These forward-looking statements include statements with respect to 2025 guidance, strategic and growth opportunities, other expectations and other non-historical information. Without limiting the foregoing, statements including the words "expect," "intend," "may," "will," "should," "would," "could," "plan," "potential," "anticipate," "believe, ...

Core Insights - OptimizeRx (OPRX) reported a strong first-quarter 2025 performance, with revenues increasing by 11% year-over-year to $21.9 million and adjusted EBITDA reaching $1.5 million, indicating a significant turnaround [1] - The company is increasingly recognized as a strategic commercialization partner, with a reported ROI of over 10:1 and a 25% script lift in six months, highlighting its value in a selective pharma spending environment [2] - More than 80% of OPRX's 2025 revenues are contracted, and the company is transitioning to a subscription-based model, which may enhance margin stability and predictability [3] - OPRX has not experienced significant regulatory pressures or pharma budget volatility, instead benefiting from a client focus on cost-effective digital solutions [4] - In a competitive digital health landscape, OPRX's integration of scalable omnichannel tools and data-driven insights may provide a sustainable advantage if executed effectively [5] Financial Performance - OPRX's shares have surged by 187.9% year-to-date, significantly outperforming the industry growth of 18% [10] - The forward 12-month price-to-sales (P/S) ratio for OPRX is 2.33X, lower than the industry average of 8.86X and its five-year median of 3.57X, indicating potential undervaluation [13] - The Zacks Consensus Estimate for OPRX's 2025 earnings per share suggests a 63.6% improvement from the 2024 level, with estimates ranging from $0.42 to $0.84 for the next year [15][16]

Investor Presentation May 6, 2025 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of federal securities laws. These forward-looking statements include statements with respect to 2025 guidance, strategic and growth opportunities, other expectations and other non-historical information. Without limiting the foregoing, statements including the words "expect," "intend," "may," "will," "should," "would," "could," "plan," "potential," "anticipate," "believe," ...